Bright Minds Biosciences Inc (DRUG.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in thousands)
| 09-2025 | 09-2024 | 09-2023 | 09-2022 | 09-2021 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 77 | 73 | 72 | 6 | N/A |
| Accounts receivable | -363 | -13 | 119 | -46 | -110 |
| Other Working Capital | 555 | 40 | -942 | 724 | 306 |
| Other Operating Activity | -8,961 | -1,950 | -6,274 | -14,272 | -7,515 |
| Operating Cash Flow | $-8,692 | $-1,850 | $-7,024 | $-13,587 | $-7,319 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -100 | -90 | -86 | -7 | N/A |
| Common Stock Issued | 82,098 | 900 | 1,218 | 4,035 | 27,745 |
| Other Financing Activity | 3,570 | 0 | 1,058 | 1,168 | -1,689 |
| Financing Cash Flow | $85,567 | $811 | $2,190 | $5,196 | $26,056 |
| Exchange Rate Effect | 313 | 12 | -45 | 259 | 224 |
| Beginning Cash Position | 5,720 | 6,748 | 11,628 | 19,760 | 800 |
| End Cash Position | 82,909 | 5,720 | 6,748 | 11,628 | 19,760 |
| Net Cash Flow | $76,876 | $-1,040 | $-4,835 | $-8,391 | $18,736 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,692 | -1,850 | -7,024 | -13,587 | -7,319 |
| Free Cash Flow | -8,692 | -1,850 | -7,024 | -13,587 | -7,319 |